SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ALMR

Alamar Biosciences, Inc. (NASDAQ:ALMR)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$26.48-$2.20 (-7.67%)
 
Market cap
$1.84B
Insider Score
Health Score
Analyst consensus
Listed since
Apr 17, 2026
Market Cap$1.84B+20.4%
Revenue (ttm)$114.05M
Net Income-$55.00M
EPS-$0.83
Shares Out69.48M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume712,583
Open$28.06
Previous Close$28.68
Day's Range$26.24 - $28.22
52-Week Range$18.85 - $39.61
Betan/a
AnalystsBuy
Price Target$32.00(+20.85%)
Earnings DateFeb 2, 2027

About ALMR

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

Address
47071 Bayside Parkway, Fremont, CA, 94538, US
Market Cap
1.84 billion
Employees
222
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$9.54M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only
Closing Price Purchase Sale
$17.56$28.80$40.04MayJulSepNov

Analyst consensus

Moderate Buy
1 Buy0 Hold0 Sell

1 firm rating ALMR in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From ALMR’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-7.67%
5 Days
-13.01%
1 Month
-15.80%
6 Months
+20.36%
1 Year
+20.36%

$ALMR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ALMR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ALMR's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ALMR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ALMR Revenue by Segment or Geography

ALMR's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New ALMR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ALMR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ALMR

ARKGARK Genomic Revolution ETF$32.95M
IWMiShares Russell 2000 ETF$10.29M
VTIVanguard Morningstar Total Stock Market ETF$7.72M
VXFVanguard Extended Market ETF$3.89M
IWOiShares Russell 2000 Growth ETF$2.50M
VTWOVanguard Russell 2000 ETF$2.43M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ALMR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
72

News check: Peer-reviewed validation and significant conference presentation of core NULISA technology demonstrate scientific progress and market adoption momentum.

Recent Insider Activity

Buys
0
Sells
28
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

ARKGARK Genomic Revolution ETF1.84%
HLTHTema Healthcare AI ETF1.16%
LFSCF/M Emerald Life Sciences Innovation ETF1.13%
TSEET. Rowe Price Small Cap ETF0.13%
RESMColumbia Research Enhanced Small Cap ETF0.06%

Weight is the stock’s share of each fund’s holdings.